|
SCOC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.39079999994518E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57641999999347E-05 |
| Normal-vs-Stage2 |
8.120300E-03 |
| Normal-vs-Stage3 |
2.363600E-04 |
| Normal-vs-Stage4 |
3.92169999807734E-08 |
| Stage1-vs-Stage2 |
4.929400E-01 |
| Stage1-vs-Stage3 |
7.674000E-01 |
| Stage1-vs-Stage4 |
2.720000E-03 |
| Stage2-vs-Stage3 |
4.580000E-01 |
| Stage2-vs-Stage4 |
4.456200E-03 |
| Stage3-vs-Stage4 |
2.329600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17970000002021E-06 |
| Normal-vs-AfricanAmerican |
1.704220E-02 |
| Normal-vs-Asian |
2.231700E-04 |
| Caucasian-vs-AfricanAmerican |
6.438200E-01 |
| Caucasian-vs-Asian |
9.622400E-01 |
| AfricanAmerican-vs-Asian |
6.420000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.36240000003784E-06 |
| Normal-vs-Female |
1.81657999999141E-05 |
| Male-vs-Female |
1.240800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.16390000000022E-05 |
| Normal-vs-Age(41-60Yrs) |
3.70480000000395E-05 |
| Normal-vs-Age(61-80Yrs) |
1.58443999999092E-05 |
| Normal-vs-Age(81-100Yrs) |
1.473790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.992400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.771800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.297000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.818600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.770800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.530400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.959600E-01 |
| Classical-VS-Follicular |
8.201800E-01 |
| Classical-VS-Other |
6.033800E-01 |
| Classical-VS-Normal |
2.20429999999716E-05 |
| Tall-VS-Follicular |
8.893400E-01 |
| Tall-VS-Other |
6.043200E-01 |
| Tall-VS-Normal |
5.701100E-03 |
| Follicular-VS-Other |
5.707800E-01 |
| Follicular-VS-Normal |
8.432000E-04 |
| Other-VS-Normal |
4.869800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66768999999567E-05 |
| Normal-vs-N1 |
3.5316000000063E-05 |
| N0-vs-N1 |
2.680800E-01 |
|
|
